Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation

N Engl J Med. 2018 Feb 1;378(5):485-486. doi: 10.1056/NEJMc1715183.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticoagulants
  • Atrial Fibrillation*
  • Dabigatran*
  • Fibrinolytic Agents
  • Humans
  • Percutaneous Coronary Intervention
  • Stroke
  • Warfarin

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Warfarin
  • Dabigatran